|1.||Roopenian, Derry C: 5 articles (11/2011 - 12/2005)|
|2.||Mezo, Adam R: 3 articles (03/2013 - 02/2010)|
|3.||Zhu, Xiaoping: 3 articles (11/2011 - 03/2011)|
|4.||Oksenhendler, E: 2 articles (12/2014 - 02/2013)|
|5.||Rath, Timo: 2 articles (10/2014 - 12/2013)|
|6.||Blumberg, Richard S: 2 articles (10/2014 - 12/2013)|
|7.||Fraley, Cara: 2 articles (03/2013 - 02/2010)|
|8.||Aoyama, Yumi: 2 articles (08/2012 - 03/2010)|
|9.||Bai, Yu: 2 articles (11/2011 - 10/2011)|
|10.||Zeng, Rongyu: 2 articles (10/2011 - 03/2011)|
|1.||Pemphigus (Pemphigus Vulgaris)
08/01/2012 - "Among the several mechanisms to explain the mode of action of IVIg, the neonatal Fc receptor for IgG (FcRn) plays important role for rapid clearance of pathogenic antibody in pemphigus induced by HD-IVIg. "
03/01/2010 - "Among the several mechanisms to explain the mode of action of IVIG, several lines of evidence have suggested that neonatal Fc receptor for immunoglobulin (Ig)G (FcRn) plays an important role for rapid clearance of pathogenic antibody in pemphigus induced by HD-IVIG. "
09/25/2015 - "Critical Role of the Neonatal Fc Receptor (FcRn) in the Pathogenic Action of Antimitochondrial Autoantibodies Synergizing with Anti-desmoglein Autoantibodies in Pemphigus Vulgaris."
12/01/2005 - "In this study, we used IgG passive transfer murine models of bullous pemphigoid (BP), pemphigus foliaceus (PF), and pemphigus vulgaris (PV) to test the hypothesis that the effect of IVIG in autoantibody-mediated cutaneous bullous diseases is to accelerate the degradation of pathogenic IgG by saturation of the MHC-like Fc receptor neonatal Fc receptor (FcRn). "
|2.||Autoimmune Diseases (Autoimmune Disease)
07/01/2009 - "Studies on mouse models have indicated that the neonatal Fc receptor (FcRn) plays important roles in a variety of autoimmune diseases. "
03/01/2013 - "The neonatal Fc receptor, FcRn, prolongs the half-life of IgG in the serum and represents a potential therapeutic target for the treatment of autoimmune disease. "
09/03/2010 - "The neonatal Fc receptor, FcRn, is responsible for the long half-life of IgG molecules in vivo and is a potential therapeutic target for the treatment of autoimmune diseases. "
08/01/2010 - "The neonatal Fc receptor as therapeutic target in IgG-mediated autoimmune diseases."
02/25/2010 - "The neonatal Fc receptor, FcRn, regulates the half-life of IgG in vivo and may be a target in the treatment of autoimmune disease. "
10/30/2014 - "Enhanced neonatal Fc receptor function improves protection against primate SHIV infection."
10/01/1996 - "The neonatal Fc receptor is not required for mucosal infection by mouse mammary tumor virus."
05/01/2015 - "The neonatal Fc receptor (FcRn) is the only receptor known to be able to transport IgG across cell barriers and may therefore modulate virus infection. "
10/30/2014 - "The localization and persistence of antibodies at these sites is influenced by the neonatal Fc receptor (FcRn), whose role in protecting against infection in vivo has not been defined. "
11/08/2011 - "Intracellular neutralization of viral infection in polarized epithelial cells by neonatal Fc receptor (FcRn)-mediated IgG transport."
09/01/2007 - "Improved tumor imaging and therapy via i.v. IgG-mediated time-sequential modulation of neonatal Fc receptor."
05/01/2006 - "We compared the ability of tetravalent vs. divalent antibody to associate/dissociate to/from CD22-positive Daudi cells, to interact with murine and human Fcgamma receptors (FcgammaR), to bind human complement component C1q, to inhibit the growth of tumor cells, to diffuse into various tissues, to be internalized by Daudi cells, to react with human neonatal Fc receptors (FcRn), and to persist in the circulation of normal mice. "
|1.||Intravenous Immunoglobulins (IVIG)
|2.||Immunoglobulin G (IgG)
|4.||IgG Receptors (Fc gamma RI)
|5.||Fc Receptors (Fc Receptor)
|9.||Cholecystokinin B Receptor
|10.||Polymeric Immunoglobulin Receptors (Polymeric Immunoglobulin Receptor)